Selmi Carlo, Cocchi Claudio A, Zuin Massimo, Gershwin M Eric
Division of Internal Medicine and Liver Unit, San Paolo Hospital School of Medicine, University of Milan, Milan, Italy.
Clin Rev Allergy Immunol. 2009 Feb;36(1):23-9. doi: 10.1007/s12016-008-8089-7.
Primary biliary cirrhosis (PBC) is a female predominant chronic disease of autoimmune pathogenesis and unknown etiology, although data suggest that genetic predisposition and environmental factors concur to its onset. Among nongenetic factors, several lines of evidence spanning from geoepidemiology to experimental findings support the role of xenobiotics, i.e., chemicals that are capable to induce molecular mimicry through cross reactivity. Indeed, specific xenobiotics are hypothesized to substitute lipoic acid residues on PBC-specific autoepitopes thus triggering autoimmunity. This is supported by data obtained with patient sera reactivities as well as animal models. The scenario is further complicated by the possibility that xenobiotic-metabolizing bacteria might also play a role. We will review the available evidence in this intriguing and rapidly growing field of research and critically discuss its potential implications.
原发性胆汁性肝硬化(PBC)是一种以女性为主的慢性疾病,其发病机制为自身免疫性,病因不明,不过有数据表明遗传易感性和环境因素共同促成了该病的发生。在非遗传因素中,从地理流行病学到实验结果的多条证据支持了外源性物质的作用,即能够通过交叉反应诱导分子模拟的化学物质。事实上,特定的外源性物质被推测可替代原发性胆汁性肝硬化特异性自身抗原表位上的硫辛酸残基,从而引发自身免疫。患者血清反应性及动物模型所获得的数据支持了这一点。外源性物质代谢细菌也可能发挥作用,这使得情况更加复杂。我们将回顾这一有趣且快速发展的研究领域中的现有证据,并批判性地讨论其潜在影响。